Another No For Vertex As Scotland Rejects Offer For Orkambi And Symkevi
The Scottish Medicines Consortium has issues over the price Vertex Pharmaceuticals is asking for its cystic fibrosis drugs, and like NICE in England it has rejected the products for use on the National Health Service.